Paid Clinical Trials Jacksonville

Discover 817 paid clinical trials in Jacksonville, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 817

Investigational CMV Vaccine Study for Volunteers Ages 9–15Investigational CMV Vaccine Study for Volunteers Ages 9–15

PHASE1

PHASE2

Sponsor:

Moderna

Location:

Jacksonville FL, Orlando FL, Tampa FL, North Charleston SCshow 43 more

Code:

NCT05575492

Conditions

Cytomegalovirus

Eligibility Criteria

Sex: All

Age: 9 - 15

Healthy Volunteers: Accepted

Interventions

mRNA-1647

Placebo

Elacestrant, CombinationOpen-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer

Recruiting

PHASE1

PHASE2

Sponsor:

Stemline Therapeutics, Inc.

Location:

Jacksonville FL, Ocala FL, Altamonte Springs FL, Dothan ALshow 37 more

Code:

NCT05563220

Conditions

Breast Cancer

Metastatic Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Elacestrant

Alpelisib

Everolimus

Ribociclib

Palbociclib

RMC-6236Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

Recruiting

PHASE3

Sponsor:

Revolution Medicines, Inc.

Location:

Jacksonville FL, Palm Bay FL, Durham NC, Nashville TNshow 17 more

Code:

NCT06625320

Conditions

Pancreatic Cancer

PDAC

PDAC - Pancreatic Ductal Adenocarcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

RMC-6236

Gemcitabine

nab-paclitaxel

Irinotecan

Liposomal irinotecan

N-acetylcysteineOral N-acetylcysteine for Retinitis Pigmentosa

Recruiting

PHASE3

Sponsor:

Johns Hopkins University

Location:

Jacksonville FL, Gainesville FL, Atlanta GA, Miami FLshow 21 more

Code:

NCT05537220

Conditions

Retinitis Pigmentosa

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

N-acetylcysteine

Placebo

TG4050A Clinical Trial Evaluating TG4050 in Head and Neck Cancer

Recruiting

PHASE1

PHASE2

Sponsor:

Transgene

Location:

Jacksonville FL

Code:

NCT04183166

Conditions

Squamous Cell Carcinoma of Head and Neck

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

TG4050

Radiation TherapyRegistry Study for Radiation Therapy Outcomes

Recruiting

Sponsor:

Proton Collaborative Group

Location:

Jacksonville FL, Orlando FL, Delray Beach FL, Atlanta GAshow 19 more

Code:

NCT01255748

Conditions

Neoplasms

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Proton Therapy, Photon Therapy, SRS, Brachytherapy

APG777A Study Evaluating APG777 in Atopic Dermatitis

Recruiting

PHASE2

Sponsor:

Apogee Therapeutics, Inc.

Location:

Jacksonville FL, Charleston SC, Margate FL, Douglasville GAshow 33 more

Code:

NCT06395948

Conditions

Atopic Dermatitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

APG777

Placebo

AGN-193408AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension

Recruiting

PHASE1

PHASE2

Sponsor:

AbbVie

Location:

Jacksonville FL, Crystal River FL, Stuart FL, Sandy Springs GAshow 33 more

Code:

NCT04499248

Conditions

Open-angle Glaucoma

Ocular Hypertension

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

AGN-193408 SR

Lumigan

Sham Administration

Lumigan Vehicle

TrastuzumabSTOP-HER2: Stopping Trastuzumab in HER2+ MBC

Recruiting

PHASE2

Sponsor:

Dana-Farber Cancer Institute

Location:

Jacksonville FL, Durham NC, Washington DC, Pittsburgh PAshow 9 more

Code:

NCT05721248

Conditions

Breast Cancer

Metastatic Breast Cancer

HER2-positive Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Cessation of anti-HER2 treatment

FM220Evaluation of FM220 in Patients With Peripheral Arterial Disease (PAD)

Recruiting

PHASE2

Sponsor:

FlowMedic

Location:

Jacksonville FL, San Antonio TX

Code:

NCT00146666

Conditions

Peripheral Arterial Disease

Intermittent Claudication

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

Intermittent compression

Giredestrant vs. FulvestrantA Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)

Recruiting

PHASE3

Sponsor:

Hoffmann-La Roche

Location:

Jacksonville FL, Tallahassee FL, Tampa FL, Fort Myers FLshow 57 more

Code:

NCT06065748

Conditions

Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Giredestrant

Fulvestrant

Abemaciclib

Palbociclib

Ribociclib